- REAGENT SERVICES Hot!
-
PRODUCTS
-
Most Popular Reagents
-
Instruments
-
Antibodies
-
ELISA Kits
-
Protein Electrophoresis and Blotting
-
Protein and Antibody Purification
-
Recombinant Proteins
-
Molecular Biology
-
Stable Cell Lines
-
Cell Isolation and Activation
-
IVD Raw Materials
-
Therapy Applications
-
Resources
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Anti-Camelid VHH]()
MonoRab™ Anti-VHH Antibodies
-
![ELISA Kits]()
ELISA Kits
-
![Precast Gels]()
SurePAGE™ Precast Gels
-
![Quatro ProAb Automated Protein and Antibody Purification System]()
AmMag™ Quatro ProAb Automated Protein and Antibody Purification System
-
![Target Proteins]()
Target Proteins
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Stable Cell Lines]()
Stable Cell Lines
-
![Cell Isolation and Activation]()
Cell Isolation and Activation
-
![Quick
Order]()
Quick Order
-
![Quick
Order]()
Quick Order
- APPLICATIONS
- RESOURCES
- ABOUT US
DNA immunization: Powerful tools for antibody drug development
Are you struggling with a problematic antigen for antibody production? GenScript's innovative DNA immunization technology is a powerful tool for antibody development against membrane proteins, such as GPCRs and ion channels, as well as other hard-to-express protein antigens including toxic, unstable or insoluble proteins. DNA immunization provides an alternative approach to traditional antigen preparation as it relies on in vivo expression of target protein, which bypasses the need for labor-intensive in vitro protein production and maximizes the likelihood of producing high specificity/high affinity antibodies against structurally-intact native protein antigens. This webinar will provide an in-depth look at the GenScript DNA Immunization platform with special focus placed on the specific strategies and technologies our experienced scientists leverage to overcome the barriers to successful antibody development against challenging antigens.
DNA immunization: a solution for antibody generation against problematic antigens Therapeutic hybridoma development DNA immunization service Anti-idiotypic antibody service - Full spectrum of immunization approaches
- One stop solution
- High throughput screening
- Solution to problematic antigens, such as membrane proteins
- Proven track record with 100% success rate
- High specificity & affinity
- Fast turnaround time: 2-3 months.
- 100% success rate
Get Quote Get Quote Get Quote Speaker-related Webinars
Introduction to immune checkpoints – the new hot target for cancer immunotherapy
Development of therapeutic antibodies against immune checkpoints for the treatment of melanoma and other cancers is gaining momentum among academia and the pharmaceutical industry.
Leveraging GenScript’s cytokines, antibodies, and protein purification tools to explore Ideas for your next grant
Wouldn't it be great if all the supplies you needed to obtain preliminary data for your next grant were available from the same vendor? This webinar will show you how to incorporate
Recombinant protein applications: choosing the best cytokine, growth factor or chemokine for your experimental system
Are you treating cells in vitro? Do your in vivo studies investigate changes in the immune response or tumor growth?
Stem cell culture: choosing the best conditions for optimal expansion and differentiation
Are you finding your rate of stem cell differentiation to be less than optimal? Choosing the appropriate conditions for stem cell expansion and differentiation is critical for obtaining a high yield of properly differentiated cells
Biologics Drug Discovery: Steps to Achieving an Antibody Drug Candidate
In the past decade, drug discovery has focused on developing biologics. In particular, antibody therapeutics have been proven to be clinically effective for disease areas such as oncology and immunology.
Latest Webinars
Find More Antibody Categories » -
